Characterization of mouse lines transgenic with the human poliovirus receptor gene

Microbial Pathogenesis

Volumn 25, Issue 1, 1998, Pages 43-54

  Deatly, A M ^a   Taffs, R E ^b   McAuliffe, J M ^c   Nawoschik, S P ^a   Coleman, J W ^a   McMullen, G ^a   Weeks Levy, C ^d   Johnson, A J ^e   Racaniello, V R ^f  

^a PFIZER INC   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c SUNY Dutchess Community College   (United States)

^d Biostar   (Canada)

^e LOUISIANA STATE UNIVERSITY   (United States)

^f Louisiana State University ^*  (United States)

Author keywords

Human poliovirus receptor; Poliovirus neurovirulence; Poliovirus susceptibility; Receptor dosage; TGM PRG 1 and TGM PRG 3; Transgenic mouse lines

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HOST SUSCEPTIBILITY; IMMUNOBLOTTING; MOUSE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN BLOTTING; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; POLIOVIRUS; RNA VIRUSES;

EID: 0031926823     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1998.0212     Document Type: Article

References (47)

1. McLaren, LC, Holland, JJ, Syverton, JT. The mammalian cell-virus relationship. I. Attachment of poliovirus to cultivated cells of primate and non-primate origin. J Exp Med 1959; 109: 475-85.
2. Holland, JJ, MacLaren, JC. The mammalian cell-virus relationship. II. Absorption, reception, and eclipse by HeLa cells. J Exp Med 1959; 109: 487-504.
3. Mendelsohn, CL, Wimmer, E, Racaniello, VR. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989; 56: 855-65.
4. Koike, S, Horie, H, Ise, I, et al. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 1990; 9: 3217-24.
5. Ren, R, Constantini, F, Gorgacz, EJ, et al. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis, Cell 1990; 63: 353-62.
6. Koike, S, Taya, C, Aoki, J, et al. Characterization of three transgenic mouse lines that carry human poliovirus receptor gene-influence of the transgene expression on pathogenesis. Arch Virol 1994; 139: 351-63.
7. Williams, AF, Barclay, AN. The immunoglobulin superfamily-domains for cell surface recognition. Ann Rev Immunol 1988; 6: 381-405.
8. Kaplan, G, Freistadt, MF, Racaniello, VR. Neutralization of poliovirus by cell receptors expressed in insect cells. J Virol 1990; 64: 4697-702.
9. Bernhardt, G, Bibb, JA, Bradley, J, et al. Molecular characterization of the cellular receptor for poliovirus. Virol 1994; 199: 105-13.
10. Koike, S, Ise, I, Nomoto, A. Functional domains of the poliovirus receptor. Proc Natl Acad Sci USA 1991; 88: 4104-8.
11. Freistadt, M, Racaniello, VR. Mutational analysis of the cellular receptor for poliovirus. J Virol 1991; 65: 3873-6.
12. Aoki, J, Koike, S, Ise, I, et al. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J Biol Chem 1994; 269: 8431-8.
13. Bernhardt, G, Harber, J, Zibert, A, et al. The poliovirus receptor: identification of domains and amino acid residues critical for virus binding. Virol 1994; 203: 344-56.
14. Selinka, HC, Zibert A, Wimmer, E. Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway. Proc Natl Acad Sci USA 1991; 88: 3598-602.
15. Bibb, JA, Bernhardt, G, Wimmer, E. The human poliovirus receptor is a serine phosphoprotein. J Virol 1994; 68: 6111-15.
16. Morrison, ME, Racaniello, VR. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J Virol 1992; 66: 2807-13.
17. Armstrong, C. Successful transfer of the Lansing strain of poliomyelitis virus from cotton rat to the white mouse. Public Health Rep 1939; 54: 2302-5.
18. Martin, A, Wychowski, C., Coudrec, T, et al. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimeric virus which is neurovirulent for mice. EMBO J 1988; 7: 2839-47.
19. Murray, MG, Bradley, HJ, Yang, X-F, et al. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science 1988; 241: 213-15.
20. Ren, R, Racaniello, VR. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 1992; 66: 296-304.
21. Racaniello, VR, Ren, R. Transgenic mice and the pathogenesis of poliomyelitis. Arch Virol 1994; 9(Suppl): 79-86.
22. Nomoto, A, Koike, S, Aoki, J. Tissue tropism and species specificity of poliovirus infection. Trends Microbiol 1994; 2: 47-51.
23. Racaniello, VR, Ren, R., Bouchard, M. Poliovirus attenuation: molecular mechanisms and practical aspects. Dev Biol Stand 1993; 78: 109-16.
24. Mattion, NM, Reilly, PA, DiMichele, SJ, et al. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses. J Virol 1994; 68: 3925-33.
25. Mattion, NM, Reilly, PA, DiMichele, SJ, et al. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D. J Virol 1995; 69: 5132-7.
26. Andino, R, Silvera, D, Suggett, SD, et al. Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science 1994; 265: 1448-51.
27. Girard, M, Martin A, van der Werf, S. Potential use of poliovirus as a vector. Biologicals 1993; 21: 371-7.
28. Ansardi, DC, Moldoveanu, Z, Porter, DC, et al. Characterization of poliovirus replicons encoding carcino-embryonic antigen. Cancer Res 1994; 54: 6359-64.
29. Moldoveanu, Z, Porter, DC, Lu, A, et al. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Vaccine 1995; 13: 1013-22.
30. Koike, S, Horie, H, Sato, Y, et al. Poliovirus-sensitive transgenic mice as a new animal model. Dev Biol Stand 1993; 78: 101-7.
31. Abe, S, Ota, Y, Koike, et al. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virol 1995; 206: 1075-83.
32. Abe, S, Ota, Y, Doi, Y, et al. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus. Virol 1995; 210: 160-6.
33. Dragunsky, E, Gardner, D, Taffs, R, et al. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test. Biologicals 1993; 21: 233-7.
34. Dragunsky, E, Taffs, R, Chernokhvostova, Y, et al. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine. Biologicals 1996; 24: 77-86.
35. Horie, H, Koike, S, Kurata, T, et al. Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. J Virol 1994; 68: 681-8.
36. Taffs, RE, Chernokhvostova, YV, Dragunsky, EM, et al. Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge. J Infect Dis 1997; 175: 441-4.
37. Ladner, MB, Martin, GA, Noble, JA, et al. cDNA cloning and expression of murine macrophage colony-stimulating factor from L929 cells. Proc Natl Acad Sci USA 1988; 85: 6706-10.
38. 32P-labeled blots. Biotechniques 1987; 5: 672-8.
39. Green, EL. Breeding systems. In: Foster HL, Small, JD, Fox, JG, Eds. The Mouse in Biomedical Research. New York: Academic Press, 1981: 91-104.
40. Koike, S, Aoki, J, Nomoto, A. Transgenic mouse for the study of poliovirus pathogenicity. In: Wimmer E, Ed. Cellular receptors for animal viruses. New York: Cold Spring Harbor Laboratory Press, 1994: 463-80.
41. Morrison, ME, Racaniello, VR. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J Virol 1992; 66: 2807-13.
42. Koike, S, Taya, C, Kurata, T, et al. Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci USA 1991; 88: 951-5.
43. Holland, JJ. Receptor affinities as major determinants of enterovirus tissue tropism in humans. Virol 1961; 15: 312-26.
44. Freistadt, MF, Kaplan, G, Racaniello, VR. Heterogenous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol 1990; 10: 5700-6.
45. Schultz, M, Crowell, RL. Eclipse of coxsackievirus infectivity: the restrictive event for a nonfusing myogenic cell line. J Gen Virol 1983; 64: 1725-34.
46. Zhang, S, Racaniello, VR. Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J Virol 1997; 71: 4915-20.
47. Jubelt, B, Ropka, SL, Goldfarb, S, et al. Susceptibility and resistance to poliovirus-induced paralysis of inbred mouse strains. J Virol 1991; 65: 1035-40.